Business
Immutep (ASX:IMM) share price hikes amid clinical trial momentum in FY21
Image source: Getty Images
Shares in clinical stage biotechnology company Immutep Ltd (ASX: IMM) are inching higher in afternoon trading, up 2.5% to 62 cents apiece.
Immutep’s share price has been on the move amid the release of its annual report today, in which several investment…
Continue Reading
-
General19 hours agoRSL NSW president Mick Bainbridge and three board members resign in wake of 7.30 investigation into conflicts of interest
-
General23 hours agoSelf-taught child drummer makes rock band debut with The Living End
-
Noosa News23 hours agoOne Nation leader Pauline Hanson calls out supermarket giants for ‘fleecing’ customers with ‘flimsy’ paper bags
-
Noosa News18 hours agoNorman Dean Lake refused bail for allegedly threatening to kill Prime Minister Anthony Albanese